Merck announced plans Monday to restructure into five main divisions after it completes its planned $41.1-billion merger with Schering-Plough. The drugmaker also assigned executive positions for the new organisation, and indicated that around 40 percent of Schering-Plough's senior leaders will occupy high-level roles in the merged company.
Full story
No comments:
Post a Comment